RHY 4.76% 6.0¢ rhythm biosciences limited

Ann: Rhythm Biosciences - Investor Presentation, page-13

  1. 930 Posts.
    lightbulb Created with Sketch. 92
    ahh k. Definitely was a presentation covering all the achievements and a good overview to potential new investors. Didn’t expect it to have materially new info embedded within.

    Seasoned RHY holders are waiting eagerly for the CE mark, TGA approval (study 7 completion which is winding up) local commercial activities and planned FDA/US activities.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.